iZafe Group

iZafe Group Net Margin

The Net Profit Margin of iZafe Group (IZAFE B.ST) as of Oct 22, 2026 is -278.35 %. In the previous year, Net Profit Margin was -257.85 % — a change of 7.95% (lower).

Net Margin

-278.35 %

YoY

7.95%

Last updated:

Net Profit Margin of iZafe Group is 2025 -278.35 % . Net Profit Margin of iZafe Group was 2024 -257.85 % . It decreases by 7.95% lower compared to the previous year.

For iZafe Group, the net margin of -278.4% is up versus -8,207.0% a few years ago.

The iZafe Group Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
-149.41 SEK
Jan 1, 2019
-161.33 SEK
Jan 1, 2020
-143.24 SEK
Jan 1, 2021
-8,207.01 SEK
Jan 1, 2022
-3,227.16 SEK
Jan 1, 2023
-1,765.92 SEK
Jan 1, 2024
-257.85 SEK
Jan 1, 2025
-278.35 SEK
The iZafe Group Net Margin history
YEARNet MarginYoY
-278.35 %+7.95%
-257.85 %-85.40%
-1,765.92 %-45.28%
-3,227.16 %-60.68%
-8,207.01 %+5,629.59%
-143.24 %-11.22%
-161.33 %+7.98%
-149.41 %-94.58%
-2,754.19 %+117.09%
-1,268.67 %+1,600.05%
-74.63 %-60.10%
-187.05 %-88.13%
-1,575.27 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

iZafe Group Stock analysis

What does iZafe Group do? iZafe Group AB develops medical and digital security solutions, including Dosell, a patented drug dispenser for home medication with remote monitoring, and MediKoll, an app providing medication side effect and allergy information. The company serves pharmaceutical companies, hospitals, care homes, and pharmacies in the global market. Its products target patients and healthcare providers seeking secure, remote medication management and personalized health information. Dosell is under development as a home medication solution, while MediKoll offers real-time data on medication reactions. The firm's revenue comes from selling these digital tools to healthcare institutions and pharmaceutical partners, focusing on improving patient safety and reducing medication errors through technology. iZafe Group AB's business model relies on the global healthcare sector's demand for innovative digital tools. The company's offerings are tailored for pharmaceutical firms, hospitals, care homes, and pharmacies, leveraging remote monitoring capabilities to address medication management challenges in home and clinical settings. iZafe Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about iZafe Group stock

Net Profit Margin of iZafe Group is -278.35 % in 2025.

Net Profit Margin of iZafe Group changed from -257.85 % to -278.35 %, representing a 7.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin iZafe Group since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's iZafe Group with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — iZafe Group

All Key Metrics — iZafe Group